MICAL2 and diffuse gastric adenocarcinoma: Data from Oncomine showed that MICAL2 expression was significantly higher in diffuse gastric adenocarcinoma, gastric intestinal-type adenocarcinoma, and gastric mixed adenocarcinoma than in normal gastric mucosa (Fig. 1C).